SOTERA HEALTH COMPANY Business Acquisition, Pro Forma Revenue
SOTERA HEALTH COMPANY (SHC) reported Business Acquisition, Pro Forma Revenue of $832.99 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2022-03-01
- SOTERA HEALTH COMPANY business acquisition, pro forma revenue for the quarter ending 2021-03-31 was $194.40M.
- SOTERA HEALTH COMPANY business acquisition, pro forma revenue for the quarter ending 2020-12-31 was $181.95M.
- SOTERA HEALTH COMPANY business acquisition, pro forma revenue for the quarter ending 2020-09-30 was $202.17M.
- SOTERA HEALTH COMPANY business acquisition, pro forma revenue for the quarter ending 2020-06-30 was $219.58M.
- SOTERA HEALTH COMPANY business acquisition, pro forma revenue for fiscal 2021 was $832.99M, a 4.37% increase from fiscal 2020.
- SOTERA HEALTH COMPANY business acquisition, pro forma revenue for fiscal 2020 was $798.10M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2021-12-31 | $832.99M 10-K · filed 2022-03-01 | |||
| 2021-03-31 | $194.40M 10-Q · filed 2021-05-13 | $376.36M derived: sum of 2 quarters · filed 2022-03-01 | $578.52M derived: sum of 3 quarters · filed 2022-03-01 | $798.10M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | $181.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $384.12M derived: sum of 2 quarters · filed 2022-03-01 | $603.70M derived: sum of 3 quarters · filed 2022-03-01 | $798.10M 10-K · filed 2022-03-01 |
| 2020-09-30 | $202.17M 10-Q · filed 2021-11-10 | $421.74M derived: sum of 2 quarters · filed 2021-11-10 | $616.14M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $219.58M 10-Q · filed 2021-08-12 | $413.98M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |